EFGARTIGIMOD ALFA vs ROZANOLIXIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
EFGARTIGIMOD ALFA vs ROZANOLIXIZUMAB: Safety Overview
| Metric | EFGARTIGIMOD ALFA | ROZANOLIXIZUMAB |
|---|---|---|
| Total FAERS Reports | 249 | 303 |
| Deaths Reported | 26 | 9 |
| Death Rate | 10.4% | 3.0% |
| Hospitalizations | 115 | 114 |
| Average Patient Age | 54.0 yrs | 61.3 yrs |
| % Female Patients | 82.5% | 60.9% |
| Manufacturer | argenx US | UCB, Inc. |
| Route | INTRAVENOUS | SUBCUTANEOUS |
| Marketing Status | Prescription | N/A |